More about

Hepatocellular Carcinoma

News
June 28, 2021
1 min read
Save

Cabozantinib-atezolizumab regimen extends PFS, not OS, in advanced liver cancer

Cabozantinib-atezolizumab regimen extends PFS, not OS, in advanced liver cancer

The combination of cabozantinib and atezolizumab prolonged PFS compared with sorafenib among patients with previously untreated advanced hepatocellular carcinoma, according to topline data released by one of the agent’s manufacturers.

News
June 26, 2021
1 min read
Save

CRP, AFP score identifies disease control, survival in HCC

CRP, AFP score identifies disease control, survival in HCC

The C-reactive protein and alpha-fetoprotein in immunotherapy score identified patients with favorable hepatocellular carcinoma disease control and survival, according to a study presented at the International Liver Congress.

News
June 25, 2021
2 min read
Save

Hepatic arterial infusion chemotherapy plus sintilimab shows promise for advanced liver cancer

Hepatic arterial infusion chemotherapy plus sintilimab shows promise for advanced liver cancer

Treatment with hepatic arterial infusion chemotherapy in combination with sintilimab allowed for surgical resection and produced survival rates similar to lesser advanced hepatocellular carcinoma, according to a presenter at The International Liver Congress.

News
June 17, 2021
1 min read
Save

Researchers find changes in ultrasound quality for HCC screening

Researchers find changes in ultrasound quality for HCC screening

Ultrasound quality changed between examinations for hepatocellular carcinoma detection in patients with cirrhosis, according to research published in Clinical Gastroenterology and Hepatology.

News
June 16, 2021
3 min read
Save

Hepatic arterial infusion chemotherapy prolongs OS vs. sorafenib in HCC subset

Hepatic arterial infusion chemotherapy prolongs OS vs. sorafenib in HCC subset

Hepatic arterial infusion chemotherapy of FOLFOX regimens demonstrated superior efficacy and OS than sorafenib as first-line treatment of advanced hepatocellular carcinoma with a heavy intrahepatic tumor burden.

News
June 10, 2021
5 min read
Save

Is radioembolization appropriate for patients with limited extrahepatic spread?

Is radioembolization appropriate for patients with limited extrahepatic spread?

There are four scenarios in which patients with HCC and extrahepatic disease (EHD) should be considered for locoregional therapy (LRT) in the form of radioembolization or other options (eg, ablation, external radiotherapy).

News
June 10, 2021
14 min read
Save

New approvals for liver cancer mark ‘golden age’ of treatment

Liver cancer — the fastest-growing cause of cancer death in the U.S. — has been notoriously difficult to treat.

News
April 19, 2021
1 min read
Save

NAFLD increases risk for hepatocellular carcinoma

NAFLD increases risk for hepatocellular carcinoma

Nonalcoholic fatty liver disease correlated with a significantly increased risk for developing cancer overall, due to the significant increased incidence in hepatocellular carcinoma, according to study results.

News
April 19, 2021
2 min read
Save

Neoadjuvant cemiplimab leads to tumor necrosis in HCC

Neoadjuvant cemiplimab leads to tumor necrosis in HCC

More than one-third of a small cohort patients with early-stage hepatocellular carcinoma achieved at least 50% tumor necrosis following neoadjuvant treatment with cemiplimab, results of a phase 2a trial showed.

News
February 26, 2021
1 min read
Save

Patients with cirrhosis prioritize early HCC detection

Patients with cirrhosis prioritize early-detection over factors like convenience when it comes to hepatocellular carcinoma surveillance, according to study results.

View more